Conference Coverage

VIDEO: HOPE-3 trial expands scope of primary cardiovascular prevention


 

AT ACC 16

References

CHICAGO – The HOPE-3 trial has brought the primary prevention of cardiovascular disease front-and-center as a hot topic of discussion at the annual meeting of the American College of Cardiology.

The large, randomized trial provides new evidence of a significant reduction in cardiovascular events in an intermediate-risk population that hasn’t previously been the focus of risk reduction via pharmacotherapy.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

The double-blind study randomized nearly 13,000 intermediate-risk men and women with no baseline cardiovascular disease to lipid-lowering with rosuvastatin (Crestor) at 10 mg/day or placebo, dual-antihypertensive therapy with candesartan plus chlorothiazide or placebo regardless of baseline blood pressure, or all three drugs or placebo. After a median of 5.6 years, the combined-therapy group had a 29% reduction in the composite of cardiovascular death or nonfatal MI or stroke compared with placebo-treated controls. Impressively, the benefit was similar regardless of baseline LDL-cholesterol level; however, only subjects with hypertension benefited from the dual-antihypertensive therapy.

In this interview, Dr. B. Hadley Wilson of the Sanger Clinic in Charlotte, N.C., explains why he considers HOPE-3 to be a giant step forward in preventive cardiolo

bjancin@frontlinemedcom.com

Recommended Reading

Swapping saturated fat and refined carbs for healthy fats could ease global CHD burden
MDedge ObGyn
Warfarin is best for anticoagulation in prosthetic heart valve pregnancies
MDedge ObGyn
Heightened emphasis on sex-specific cardiovascular risk factors
MDedge ObGyn
VIDEO: Migraine plus aura doubles ischemic stroke rate
MDedge ObGyn
Cardiovascular abnormalities persist after preeclamptic pregnancy
MDedge ObGyn
Heart attack patients getting younger, fatter, and less healthy
MDedge ObGyn
Brain imaging suggests link between stress and cardiovascular events
MDedge ObGyn
Arterial calcium findings on mammograms can predict heart disease risk
MDedge ObGyn
Breast cancer treatment linked to mild systolic dysfunction
MDedge ObGyn
Women with suspected CAD classified as lower risk than men
MDedge ObGyn